Biosynthetic origin of the galactosamine substituent of Arabinogalactan in Mycobacterium tuberculosis.
Skovierová
Henrieta
H
Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682, USA.
Larrouy-Maumus
Gérald
G
Pham
Ha
H
Belanová
Martina
M
Barilone
Nathalie
N
Dasgupta
Arunava
A
Mikusová
Katarina
K
Gicquel
Brigitte
B
Gilleron
Martine
M
Brennan
Patrick J
PJ
Puzo
Germain
G
Nigou
Jérôme
J
Jackson
Mary
M
D000483:Alleles; D002462:Cell Membrane / Q000378:metabolism; D005685:Galactans / Q000737:chemistry*; D005688:Galactosamine / Q000737:chemistry*; D006031:Glycosylation; D008055:Lipids / Q000737:chemistry; D008954:Models, Biological; D009154:Mutation; D020102:Mycobacterium smegmatis / Q000378:metabolism; D009169:Mycobacterium tuberculosis / Q000378:metabolism*; D010641:Phenotype; D011134:Polysaccharides / Q000737:chemistry; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D005685:Galactans; D008055:Lipids; D011134:Polysaccharides; D005688:Galactosamine; C005653:arabinogalactan